The earnings call highlighted significant revenue growth, record new patient starts, and successful marketing strategies, contributing to a positive outlook. However, ongoing financial losses and anticipated inventory challenges during the transition from Ascensia present notable concerns.

Company Guidance

During the Senseonics Third Quarter 2025 Earnings Conference Call, significant growth metrics were highlighted. The company reported a 90% year-over-year increase in third-quarter revenue, driven by a 160% rise in new patient shipments. Direct-to-consumer (DTC) marketing investments led to a 300% year-over-year and 85% sequential increase in patient leads, with 60% of new patients originating from DTC advertising. New patient starts reached record levels, with new insertions up nearly 150% year-over-year. The installed base grew over 150% year-over-year, and the number of providers prescribing Eversense increased by more than 55%. The Eon Care network, supporting insertion capacity, now accounts for approximately 25% of all insertions nationwide. Additionally, the company anticipates gross profit margins to improve from 40% in 2025 to approximately 50% in 2026, aiming for 70% at scale. The European launch of Eversense 365 is planned for the first half of 2026, following CE mark approval expected by the end of 2025.

Exceptional Third Quarter Performance

Senseonics reported a 90% year-over-year revenue growth in Q3 2025, with significant contributions from new patient shipments, which grew 160% compared to the previous year.

Successful Direct-to-Consumer Strategy

Investments in direct-to-consumer marketing led to a 300% increase in patient leads year-over-year and 85% sequentially, with 60% of new patients originating from DTC advertising.

Record New Patient Starts

September saw the highest number of new patient starts in a month, contributing to the highest quarter in the company's history. New insertions increased nearly 150% year-over-year.

Gross Margin Improvements

Gross profit margins improved to over 40% from 25% at the end of 2024. Future projections estimate gross margins to reach 50% in 2026 and approximately 70% at scale.

European Expansion Plans

The CE mark application for Eversense 365 in Europe is expected to be approved by the end of 2025, with a planned launch in the first half of 2026 using Senseonics' own sales force.

Partnership with Sequel

Senseonics is working towards integrating Eversense 365 with Sequel's twiist insulin delivery system, expected to be a growth driver in 2026.

Senseonics Holdings (SENS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SENS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.37 / -	-0.8	―	―	―
Aug 06, 2025	2025 (Q2)	-0.40 / -0.40	-0.6	33.33% (+0.20)	―
May 08, 2025	2025 (Q1)	-0.45 / -0.40	-0.6	33.33% (+0.20)	―
Mar 03, 2025	2024 (Q4)	-0.64 / -0.40	-0.6	33.33% (+0.20)	―
Nov 07, 2024	2024 (Q3)	-0.68 / -0.80	-0.8	0.00% (0.00)	―
Aug 08, 2024	2024 (Q2)	-0.60 / -0.60	-0.8	25.00% (+0.20)	―
May 13, 2024	2024 (Q1)	-0.60 / -0.60	0	―	―
Feb 29, 2024	2023 (Q4)	-0.79 / -0.60	0.4	-250.00% (-1.00)	―
Nov 09, 2023	2023 (Q3)	-0.70 / -0.80	-2.6	69.23% (+1.80)	―
Aug 10, 2023	2023 (Q2)	-0.76 / -0.80	-0.6	-33.33% (-0.20)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SENS Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 05, 2025	$6.73	$6.22	-7.58%
Aug 06, 2025	$9.73	$9.26	-4.83%
May 08, 2025	$14.74	$12.50	-15.20%
Mar 03, 2025	$17.40	$14.04	-19.31%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Senseonics Holdings Inc. (SENS) report earnings?

Senseonics Holdings Inc. (SENS) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Senseonics Holdings Inc. (SENS) earnings time?

Senseonics Holdings Inc. (SENS) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SENS EPS forecast?

SENS EPS forecast for the fiscal quarter 2025 (Q3) is -0.37.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing